FORBES-TATE

Lobbying for TARSUS PHARMACEUTICALS · Life sciences product developer.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 18, 2025

Lobbying activity 1

Health Issues

Issues related to Education and advocacy pertaining to life science products and pipeline.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.